LINQ II Insertable Cardiac Monitor vs Vivid E80

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by GE HealthCare

AI Verdict

These tools are adjacent rather than direct competitors, as they address different aspects of cardiac diagnostics. The Medtronic LINQ II is an insertable cardiac monitor focused on long-term, continuous heart rhythm monitoring and arrhythmia detection. In contrast, GE HealthCare's Vivid E80 is an AI-powered ultrasound system designed for real-time cardiovascular imaging and automated measurements.

Choose LINQ II Insertable Cardiac Monitor if…

Choose the Medtronic LINQ II if you require long-term, continuous monitoring of a patient's heart rhythm to diagnose infrequent or paroxysmal arrhythmias that may not be captured during shorter diagnostic windows. This AI-powered insertable cardiac monitor is ideal for extended surveillance, offering up to 4.5 years of monitoring with remote management capabilities and enhanced accuracy for arrhythmia detection, including pediatric patients.

View LINQ II Insertable Cardiac Monitor →

Choose Vivid E80 if…

Choose GE HealthCare's Vivid E80 if your clinical setting demands advanced, real-time cardiovascular ultrasound imaging with integrated AI to enhance diagnostic precision and workflow efficiency during examinations. This system is best suited for immediate, comprehensive assessment of cardiac structure and function, leveraging AI for automated measurements and optimized image processing.

View Vivid E80 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature LINQ II Insertable Cardiac Monitor Vivid E80
Pricing Unknown Quote-based
Deployment Subcutaneous implant with remote monitoring via mobile app or home communicator. On-premise (medical device)
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Unknown Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

LINQ II Insertable Cardiac Monitor

Tool A (LINQ II) offers remote programming capabilities and a patient-facing mobile app (MyCareLink Heartu2122), enhancing convenience for both clinicians and patients in managing the long-term monitoring device. While Tool B (Vivid E80) streamlines clinical workflow with AI-driven automation during an ultrasound exam, Tool A's features extend usability beyond the immediate clinical setting to ongoing patient care.

Clinical Value

LINQ II Insertable Cardiac Monitor

Tool A (LINQ II) provides continuous, long-term heart rhythm monitoring for up to 4.5 years with AI-powered accuracy, which is crucial for diagnosing intermittent and elusive arrhythmias that might otherwise be missed. While Tool B (Vivid E80) enhances diagnostic precision and efficiency for cardiovascular ultrasound, Tool A's extended, continuous data collection offers a unique and profound benefit for long-term arrhythmia management and diagnosis.

Pricing & Value

Tie

Both tools utilize an enterprise or quote-based pricing model, with no publicly disclosed details or free trial options available. Without specific cost information or detailed value propositions for either product, it is not possible to definitively compare their pricing and overall value.

Enterprise Readiness

LINQ II Insertable Cardiac Monitor

Both products are from highly reputable global healthcare companies (Medtronic and GE HealthCare) and are HIPAA compliant and FDA cleared, indicating strong foundational readiness. However, Tool A explicitly targets a broader range from solo practices to large health systems with a hybrid deployment model and has been adopted by over a million patients, suggesting a more proven and flexible enterprise footprint.

Innovation

LINQ II Insertable Cardiac Monitor

Tool A (LINQ II) demonstrates significant innovation with its AI-powered, insertable cardiac monitor offering up to 4.5 years of continuous monitoring, remote programming, and an innovative PVC detection algorithm, including a pediatric indication. While Tool B (Vivid E80) integrates advanced AI into ultrasound for automated measurements, Tool A's long-duration, remote, and insertable technology represents a more transformative approach to cardiac diagnostics.

Support & Docs

Tie

The provided structured facts do not offer specific details regarding the support channels, documentation quality, or availability for either Medtronic's LINQ II or GE HealthCare's Vivid E80. As both are products from major medical device manufacturers, robust support is expected, but without comparative information, a distinction cannot be made.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature LINQ II Insertable Cardiac Monitor Vivid E80
Name LINQ II Insertable Cardiac Monitor Vivid E80
Company Medtronic GE HealthCare
Description An advanced, AI-powered insertable cardiac monitor providing long-term, continuous heart rhythm monitoring with remote programming and enhanced accuracy for diagnosing arrhythmias. An advanced AI-powered ultrasound system for cardiovascular imaging, enhancing diagnostic precision and workflow efficiency through integrated AI features.
Categories Cardiology AI, Clinical Decision Support & Reference Cardiology AI, Radiology & Imaging AI
Specialties Cardiology Cardiology, Radiology
Key AI Features AccuRhythmu2122 AI algorithms for enhanced accuracy, Innovative PVC detection algorithm AI Auto Measure 2D, Easy AutoEF (AI-based ejection fraction measurement), AI Cardiac Auto Doppler, AI FlexiViews LAA

Videos

Demos, reviews, and walkthroughs featuring LINQ II Insertable Cardiac Monitor and Vivid E80.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Medtronic LINQ II is an insertable cardiac monitor designed for long-term, continuous heart rhythm monitoring to diagnose arrhythmias. In contrast, the GE HealthCare Vivid E80 is an advanced AI-powered ultrasound system used for cardiovascular imaging to enhance diagnostic precision and workflow efficiency.
The LINQ II utilizes AccuRhythmu2122 AI algorithms to enhance the accuracy of arrhythmia detection and diagnosis, including innovative PVC detection. The Vivid E80 integrates AI for automated measurements in cardiovascular imaging, such as AI Auto Measure 2D for left ventricle dimensions, Easy AutoEF for ejection fraction, and AI Cardiac Auto Doppler.
Yes, the Medtronic LINQ II has a pediatric indication for patients aged 2 years and older. The provided information for the GE HealthCare Vivid E80 does not specify a pediatric indication.
The LINQ II provides continuous heart rhythm monitoring for up to 4.5 years. The Vivid E80 is an ultrasound system used for real-time diagnostic imaging, meaning its use is for specific imaging sessions rather than continuous long-term monitoring.
The LINQ II offers remote programming capability and data transmission via the MyCareLink Heartu2122 mobile app or MyCareLink Relayu2122 home communicator. The Vivid E80 features DICOMu00ae connectivity for image processing and reporting, but its description does not detail remote patient management or direct remote access for physicians.
AI Tool Finder
AI-powered search. Results may not be comprehensive.